Etentamig
Based on 1 Customer Validation
Etentamig (ABBV-383; TNB 383B) is a T cell engager targeting BCMA and CD3. Etentamig redirects T cell-mediated cytotoxicity by binding BCMA (Kd ≈ 0.7 nM) and activating the T cell co-receptor CD3 (Kd = 1.3 μM), mediates BCMA-specific plasma cell killing and target cell lysis, and has low-activation properties that decouple T cell activation from cytokine release. Etentamig exhibits anti-myeloma efficacy and can be used for research on relapsed/refractory multiple myeloma.
For research use only. We do not sell to patients.
- Purity : 99%
- CAS No.: 2490552-52-6
- Molecular Weight:123.8 kDa
-
Storage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Isotype
G4_L-kappa_VH-VH-h-CH2-CH3
Recommend Isotype Controls
Species Reactivity
Human
|
human CD3 1.3 μM (Kd) |
BCMA ≈ 0.7 |
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
G4_L-kappa_VH-VH-h-CH2-CH3
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Loaded ABBV-383 on AHC2 biosensor, can bind BCMA/TNFRSF17 Protein, Human (HEK293, His, HY-P72847) with an affinity constant of 1.731E-11 M as determined in BLI assay. -
Loaded ABBV-383 on AHC2 biosensor, can bind CD3D-CD3E Heterodimer Protein, Human (HEK293, Fc-Flag&Fc-His, HY-P70434) with an affinity constant of 3.674E-07 M as determined in BLI assay. -
Flow cytometric analysis of 1X106 Juakat cells with Etentamig (HY-P990785, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. AF 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG4 (S228P) kappa (HY-P99003, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
Chemical Information
-
CAS No. 2490552-52-6
-
Appearance Liquid
-
Molecular Weight 123.8 kDa
-
Color Colorless to light yellow
-
SMILES
[Etentamig]
-
Synonyms
ABBV-383; TNB 383B
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (269 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
[1]. D'Souza A, et al. A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen × CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2022 Nov 01;40(31):3576-3586. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)